Graviton
Graviton develops novel therapeutics for the treatment of autoimmune, cancer, certain genetic, fibrotic, and other serious diseases. TDI01, a highly selective, potent inhibitor of Rho/Rho-associated coiled-coil containing protein kinase 2 (ROCK2) is currently being studied in the United States for the treatment of idiopathic pulmonary fibrosis (IPF). Graviton anticipates entering human clinical studies in the U.S. in 2021.
Domain
graviton.bio
Country
United StatesIndustry
BiotechnologyEmployees
11-50
Last Funding
$39.8M
Founded
2019
Tech Stack (10 technologies)
Frequently Asked Questions
What technologies does Graviton use?+
Graviton uses 10 technologies including SeedProd Coming Soon, WordPress, jQuery.
What industry is Graviton in?+
Graviton operates in the Biotechnology industry.
Where is Graviton based?+
Graviton is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026